Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
European Heart Journal|February 17, 2021
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonanceTushar Kotecha, Daniel S Knight, Yousuf Razvi, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
Open Heart|March 16, 2021
COVID-19 and its impact on the cardiovascular systemSaud Ahmed Khawaja, Poornima Mohan, Richard Jabbour, et al.
Ebiomedicine|December 21, 2022
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Shubha Talwar, Andy Cross, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
The Lancet. Respiratory Medicine|October 10, 2021
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort studyRachael A Evans, Hamish McAuley, Ewen M Harrison, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial HypertensionJoshua Hodgson, Emilia M Swietlik, Richard M Salmon, et al.
Circulation. Genomic and Precision Medicine|December 15, 2020
Bayesian Inference Associates Rare <i>KDR</i> Variants with Specific Phenotypes in Pulmonary Arterial HypertensionEmilia M Swietlik, Daniel Greene, Na Zhu, et al.
Nature Communications|April 14, 2018
Identification of rare sequence variation underlying heritable pulmonary arterial hypertensionStefan Gräf, Matthias Haimel, Marta Bleda, et al.
ERJ Open Research|October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort studyOlivia C Leavy, Richard J Russell, Ewen M Harrison, et al.
Pageof 10